<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31780563</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>295</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>17</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules.</ArticleTitle><Pagination><StartPage>673</StartPage><EndPage>689</EndPage><MedlinePgn>673-689</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA119.010617</ELocationID><Abstract><AbstractText>Insoluble, hyperubiquitylated TAR DNA-binding protein of 43 kDa (TDP-43) in the central nervous system characterizes frontotemporal dementia and ALS in many individuals with these neurodegenerative diseases. The causes for neuropathological TDP-43 aggregation are unknown, but it has been suggested that stress granule (SG) formation is important in this process. Indeed, in human embryonic kidney HEK293E cells, various SG-forming conditions induced very strong TDP-43 ubiquitylation, insolubility, and reduced splicing activity. Osmotic stress-induced SG formation and TDP-43 ubiquitylation occurred rapidly and coincided with colocalization of TDP-43 and SG markers. Washout experiments confirmed the rapid dissolution of SGs, accompanied by normalization of TDP-43 ubiquitylation and solubility. Surprisingly, interference with the SG process using a protein kinase R-like endoplasmic reticulum kinase inhibitor (GSK2606414) or the translation blocker emetine did not prevent TDP-43 ubiquitylation and insolubility. Thus, parallel pathways may lead to pathological TDP-43 modifications independent of SG formation. Using a panel of kinase inhibitors targeting signaling pathways of the osmotic shock inducer sorbitol, we could largely rule out the stress-activated and extracellular signal-regulated protein kinase modules and glycogen synthase kinase 3&#x3b2;. For arsenite, but not for sorbitol, quenching oxidative stress with <i>N</i>-acetylcysteine did suppress both SG formation and TDP-43 ubiquitylation and insolubility. Thus, sodium arsenite appears to promote SG formation and TDP-43 modifications via oxidative stress, but sorbitol stimulates TDP-43 ubiquitylation and insolubility via a novel pathway(s) independent of SG formation. In conclusion, pathological TDP-43 modifications can be mediated via multiple distinct pathways for which SGs are not essential.</AbstractText><CopyrightInformation>&#xa9; 2020 Hans et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hans</LastName><ForeName>Friederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 72076 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glasebach</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of T&#xfc;bingen, 72076 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahle</LastName><ForeName>Philipp J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-8587-1731</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 72076 T&#xfc;bingen, Germany philipp.kahle@uni-tuebingen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of T&#xfc;bingen, 72076 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C576403">7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>506T60A25R</RegistryNumber><NameOfSubstance UI="D013012">Sorbitol</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>JAC85A2161</RegistryNumber><NameOfSubstance UI="D000225">Adenine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009997" MajorTopicYN="N">Osmotic Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013012" MajorTopicYN="N">Sorbitol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA splicing</Keyword><Keyword MajorTopicYN="N">TAR DNA-binding protein 43 (TDP-43) (TARDBP)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">osmotic shock</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">protein kinase</Keyword><Keyword MajorTopicYN="N">signal transduction</Keyword><Keyword MajorTopicYN="N">stress granule</Keyword><Keyword MajorTopicYN="N">ubiquitylation (ubiquitination)</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest with the contents of this article</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31780563</ArticleId><ArticleId IdType="pmc">PMC6970928</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA119.010617</ArticleId><ArticleId IdType="pii">S0021-9258(17)49926-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mackenzie I. R., Rademakers R., and Neumann M. (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995&#x2013;1007 10.1016/S1474-4422(10)70195-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., Bruce J., Schuck T., Grossman M., Clark C. M., McCluskey L. F., Miller B. L., Masliah E., Mackenzie I. R., Feldman H., et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., and Buratti E. (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 138, 95&#x2013;111 10.1111/jnc.13625</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., and Ratti A. (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051&#x2013;1061 10.1111/j.1471-4159.2009.06383.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K., Leystra-Lantz C., Yang W., Jaffee H., and Strong M. J. (2009) Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability: implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res. 1305, 168&#x2013;182 10.1016/j.brainres.2009.09.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pubmed">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M. E., Mackenzie I. R., Capell A., Schmid B., Neumann M., and Haass C. (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841&#x2013;2857 10.1038/emboj.2010.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y. J., Vanderwyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., Sherman M., Petrucelli L., and Wolozin B. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE 5, e13250 10.1371/journal.pone.0013250</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C. M., Cenik B., Sephton C. F., Dries D. R., Mayer P. 3rd, Good S. K., Johnson B. A., Herz J., and Yu G. (2011) TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell. Biol. 31, 1098&#x2013;1108 10.1128/MCB.01279-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K. K., Aulas A., Destroismaisons L., Pickles S., Beleac E., Camu W., Rouleau G. A., and Vande Velde C. (2011) TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 20, 1400&#x2013;1410 10.1093/hmg/ddr021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E., Neumann M., Tahirovic S., Rodde R., Dormann D., and Haass C. (2012) Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem. 287, 23079&#x2013;23094 10.1074/jbc.M111.328757</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.328757</ArticleId><ArticleId IdType="pmc">PMC3391091</ArticleId><ArticleId IdType="pubmed">22563080</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M. K., St&#xe5;hlberg A., Arvidsson Y., Olofsson A., Semb H., Stenman G., Nilsson O., and Aman P. (2008) The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 9, 37 10.1186/1471-2121-9-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P., and Kedersha N. (2008) Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 33, 141&#x2013;150 10.1016/j.tibs.2007.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2007.12.003</ArticleId><ArticleId IdType="pubmed">18291657</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly N., Gorman A. M., Gupta S., and Samali A. (2013) The eIF2&#x3b1; kinases: their structures and functions. Cell Mol. Life Sci. 70, 3493&#x2013;3511 10.1007/s00018-012-1252-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1252-6</ArticleId><ArticleId IdType="pubmed">23354059</ArticleId></ArticleIdList></Reference><Reference><Citation>Panas M. D., Ivanov P., and Anderson P. (2016) Mechanistic insights into mammalian stress granule dynamics. J. Cell Biol. 215, 313&#x2013;323 10.1083/jcb.201609081</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201609081</ArticleId><ArticleId IdType="pmc">PMC5100297</ArticleId><ArticleId IdType="pubmed">27821493</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., and Vande Velde C. (2015) Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front. Cell Neurosci. 9, 423 10.3389/fncel.2015.00423</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. R., King O. D., Shorter J., and Gitler A. D. (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361&#x2013;372 10.1083/jcb.201302044</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E., Haass C., and Dormann D. (2013) Stress granules in neurodegeneration&#x2014;lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 280, 4348&#x2013;4370 10.1111/febs.12287</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12287</ArticleId><ArticleId IdType="pubmed">23587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. (2012) Regulated protein aggregation: stress granules and neurodegeneration. Mol. Neurodegener. 7, 56 10.1186/1750-1326-7-56</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-56</ArticleId><ArticleId IdType="pmc">PMC3519755</ArticleId><ArticleId IdType="pubmed">23164372</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A. C., Kim H. J., Hart M. P., Chen-Plotkin A. S., Johnson B. S., Fang X., Armakola M., Geser F., Greene R., Lu M. M., Padmanabhan A., Clay-Falcone D., McCluskey L., Elman L., Juhr D., et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069&#x2013;1075 10.1038/nature09320</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I. R., Nicholson A. M., Sarkar M., Messing J., Purice M. D., Pottier C., Annu K., Baker M., Perkerson R. B., Kurti A., Matchett B. J., Mittag T., Temirov J., Hsiung G. R., Krieger C., et al. (2017) TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron 95, 808&#x2013;816.e9 10.1016/j.neuron.2017.07.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Brocker C., Thompson D. C., and Vasiliou V. (2012) The role of hyperosmotic stress in inflammation and disease. Biomol. Concepts 3, 345&#x2013;364 10.1515/bmc-2012-0001</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bmc-2012-0001</ArticleId><ArticleId IdType="pmc">PMC3438915</ArticleId><ArticleId IdType="pubmed">22977648</ArticleId></ArticleIdList></Reference><Reference><Citation>Burg M. B., Ferraris J. D., and Dmitrieva N. I. (2007) Cellular response to hyperosmotic stresses. Physiol. Rev. 87, 1441&#x2013;1474 10.1152/physrev.00056.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00056.2006</ArticleId><ArticleId IdType="pubmed">17928589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Naguro I., Ichijo H., and Watanabe K. (2016) Mitogen-activated protein kinases as key players in osmotic stress signaling. Biochim. Biophys. Acta 1860, 2037&#x2013;2052 10.1016/j.bbagen.2016.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2016.05.032</ArticleId><ArticleId IdType="pubmed">27261090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z., Xu S., Joazeiro C., Cobb M. H., and Hunter T. (2002) The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol. Cell 9, 945&#x2013;956 10.1016/S1097-2765(02)00519-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00519-1</ArticleId><ArticleId IdType="pubmed">12049732</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatake R. J., O'Neill M. M., Kennedy C. A., Wayne A. L., Jakes S., Wu D., Kugler S. Z. Jr, Kashem M. A., Kaplita P., and Snow R. J. (2008) Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochem. Biophys. Res. Commun. 377, 120&#x2013;125 10.1016/j.bbrc.2008.09.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.09.087</ArticleId><ArticleId IdType="pubmed">18834865</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe J., Kusuhara M., Ulevitch R. J., Berk B. C., and Lee J. D. (1996) Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 271, 16586&#x2013;16590 10.1074/jbc.271.28.16586</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.28.16586</ArticleId><ArticleId IdType="pubmed">8663194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F., Fiesel F. C., Strong J. C., J&#xe4;ckel S., Rasse T. M., Geisler S., Springer W., Schulz J. B., Voigt A., and Kahle P. J. (2014) UBE2E ubiquitin-conjugating enzymes and ubiquitin isopeptidase Y regulate TDP-43 protein ubiquitination. J. Biol. Chem. 289, 19164&#x2013;19179 10.1074/jbc.M114.561704</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.561704</ArticleId><ArticleId IdType="pmc">PMC4081952</ArticleId><ArticleId IdType="pubmed">24825905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F., Eckert M., von Zweydorf F., Gloeckner C. J., and Kahle P. J. (2018) Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem. 293, 16083&#x2013;16099 10.1074/jbc.RA118.003440</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003440</ArticleId><ArticleId IdType="pmc">PMC6187624</ArticleId><ArticleId IdType="pubmed">30120199</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., D&#xf6;rk T., Zuccato E., Pagani F., Romano M., and Baralle F. E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774&#x2013;1784 10.1093/emboj/20.7.1774</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.7.1774</ArticleId><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F. C., Weber S. S., Supper J., Zell A., and Kahle P. J. (2012) TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res. 40, 2668&#x2013;2682 10.1093/nar/gkr1082</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1082</ArticleId><ArticleId IdType="pmc">PMC3315294</ArticleId><ArticleId IdType="pubmed">22121224</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F. C., Voigt A., Weber S. S., Van den Haute C., Waldenmaier A., G&#xf6;rner K., Walter M., Anderson M. L., Kern J. V., Rasse T. M., Schmidt T., Springer W., Kirchner R., Bonin M., Neumann M., Baekelandt V., Alunni-Fabbroni M., Schulz J. B., and Kahle P. J. (2010) Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 29, 209&#x2013;221 10.1038/emboj.2009.324</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.324</ArticleId><ArticleId IdType="pmc">PMC2808372</ArticleId><ArticleId IdType="pubmed">19910924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. C., Huang W. C., Lin J. H., Kao T. J., Lin H. C., Lee K. H., Lin H. C., Shen C. J., Chang W. C., and Huang C. C. (2018) Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology. J. Biomed Sci. 25, 76 10.1186/s12929-018-0479-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-018-0479-4</ArticleId><ArticleId IdType="pmc">PMC6223059</ArticleId><ArticleId IdType="pubmed">30404641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron M. L., Lonskaya I., Sharpe K., Weerasinghe P. P., Algarzae N. K., Shekoyan A. R., and Moussa C. E. (2013) Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J. Biol. Chem. 288, 4103&#x2013;4115 10.1074/jbc.M112.419945</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.419945</ArticleId><ArticleId IdType="pmc">PMC3567661</ArticleId><ArticleId IdType="pubmed">23258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Denison S. R., Wang F., Becker N. A., Sch&#xfc;le B., Kock N., Phillips L. A., Klein C., and Smith D. I. (2003) Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22, 8370&#x2013;8378 10.1038/sj.onc.1207072</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207072</ArticleId><ArticleId IdType="pubmed">14614460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon Y. T., and Ciechanover A. (2017) The ubiquitin code in the ubiquitin-proteasome system and autophagy. Trends Biochem. Sci. 42, 873&#x2013;886 10.1016/j.tibs.2017.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.09.002</ArticleId><ArticleId IdType="pubmed">28947091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Cho M. R., Li W., Yacono P. W., Chen S., Gilks N., Golan D. E., and Anderson P. (2000) Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 151, 1257&#x2013;1268 10.1083/jcb.151.6.1257</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.151.6.1257</ArticleId><ArticleId IdType="pmc">PMC2190599</ArticleId><ArticleId IdType="pubmed">11121440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N., Panas M. D., Achorn C. A., Lyons S., Tisdale S., Hickman T., Thomas M., Lieberman J., McInerney G. M., Ivanov P., and Anderson P. (2016) G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits. J. Cell Biol. 212, 845&#x2013;860 10.1083/jcb.201508028</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201508028</ArticleId><ArticleId IdType="pmc">PMC4810302</ArticleId><ArticleId IdType="pubmed">27022092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevilacqua E., Wang X., Majumder M., Gaccioli F., Yuan C. L., Wang C., Zhu X., Jordan L. E., Scheuner D., Kaufman R. J., Koromilas A. E., Snider M. D., Holcik M., and Hatzoglou M. (2010) eIF2&#x3b1; phosphorylation tips the balance to apoptosis during osmotic stress. J. Biol. Chem. 285, 17098&#x2013;17111 10.1074/jbc.M110.109439</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.109439</ArticleId><ArticleId IdType="pmc">PMC2878040</ArticleId><ArticleId IdType="pubmed">20338999</ArticleId></ArticleIdList></Reference><Reference><Citation>Bounedjah O., Hamon L., Savarin P., Desforges B., Curmi P. A., and Pastr&#xe9; D. (2012) Macromolecular crowding regulates assembly of mRNA stress granules after osmotic stress: new role for compatible osmolytes. J. Biol. Chem. 287, 2446&#x2013;2458 10.1074/jbc.M111.292748</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.292748</ArticleId><ArticleId IdType="pmc">PMC3268405</ArticleId><ArticleId IdType="pubmed">22147700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., James J. L., Parker S. J., Lidgerwood G. E., Duncan C., Meyerowitz J., Nonaka T., Hasegawa M., Kanninen K. M., Grubman A., Liddell J. R., Crouch P. J., and White A. R. (2013) Kinase inhibitor screening identifies cyclin-dependent kinases and glycogen synthase kinase 3 as potential modulators of TDP-43 cytosolic accumulation during cell stress. PLoS ONE 8, e67433 10.1371/journal.pone.0067433</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067433</ArticleId><ArticleId IdType="pmc">PMC3694067</ArticleId><ArticleId IdType="pubmed">23840699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes K., Nikolakaki E., Plyte S. E., Totty N. F., and Woodgett J. R. (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803&#x2013;808 10.1002/j.1460-2075.1993.tb05715.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb05715.x</ArticleId><ArticleId IdType="pmc">PMC413270</ArticleId><ArticleId IdType="pubmed">8382613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamann I., and Klotz L. O. (2013) Arsenite-induced stress signaling: modulation of the phosphoinositide 3&#x2032;-kinase/Akt/FoxO signaling cascade. Redox Biol. 1, 104&#x2013;109 10.1016/j.redox.2012.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2012.11.010</ArticleId><ArticleId IdType="pmc">PMC3757669</ArticleId><ArticleId IdType="pubmed">24024143</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison A. F., and Shorter J. (2017) RNA-binding proteins with prion-like domains in health and disease. Biochem. J. 474, 1417&#x2013;1438 10.1042/BCJ20160499</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160499</ArticleId><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Cook C., Gendron T. F., Jansen-West K., Del Rosso G., Daughrity L. M., Castanedes-Casey M., Kurti A., Stankowski J. N., Disney M. D., Rothstein J. D., Dickson D. W., Fryer J. D., Zhang Y. J., and Petrucelli L. (2019) Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener. 14, 9 10.1186/s13024-019-0310-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Fan B., Yang P., Temirov J., Messing J., Kim H. J., and Taylor J. P. (2019) Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. Elife 8, e39578 10.7554/eLife.39578</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39578</ArticleId><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., and Cohen T. J. (2019) Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation. J. Biol. Chem. 294, 3696&#x2013;3706 10.1074/jbc.RA118.006351</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006351</ArticleId><ArticleId IdType="pmc">PMC6416430</ArticleId><ArticleId IdType="pubmed">30630951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Lu S., Yu H., Chen C., Melamed Z., Guo L., Shorter J., Da Cruz S., and Cleveland D. W. (2019) Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339&#x2013;357.e7 10.1016/j.neuron.2019.02.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J. R., Gleixner A. M., Mauna J. C., Gomes E., DeChellis-Marks M. R., Needham P. G., Copley K. E., Hurtle B., Portz B., Pyles N. J., Guo L., Calder C. B., Wills Z. P., Pandey U. B., Kofler J. K., et al. (2019) RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron 102, 321&#x2013;338.e8 10.1016/j.neuron.2019.01.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Gomes E., Guo L., Mojsilovic-Petrovic J., Tran V., Kalb R. G., Shorter J., and Bonini N. M. (2018) Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell 71, 703&#x2013;717.e9 10.1016/j.molcel.2018.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. (2019) The evolution of phase-separated TDP-43 in stress. Neuron 102, 265&#x2013;267 10.1016/j.neuron.2019.03.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.041</ArticleId><ArticleId IdType="pmc">PMC6816464</ArticleId><ArticleId IdType="pubmed">30998893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wobst H. J., Delsing L., Brandon N. J., and Moss S. J. (2017) Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant. PLoS ONE 12, e0177181 10.1371/journal.pone.0177181</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177181</ArticleId><ArticleId IdType="pmc">PMC5433705</ArticleId><ArticleId IdType="pubmed">28510586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T. J., Hwang A. W., Unger T., Trojanowski J. Q., and Lee V. M. (2012) Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 31, 1241&#x2013;1252 10.1038/emboj.2011.471</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.471</ArticleId><ArticleId IdType="pmc">PMC3297986</ArticleId><ArticleId IdType="pubmed">22193716</ArticleId></ArticleIdList></Reference><Reference><Citation>Prpar Mihevc S., Baralle M., Buratti E., and Rogelj B. (2016) TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci. Rep. 6, 33996 10.1038/srep33996</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33996</ArticleId><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H. W., Won H. R., Lee D. H., and Kwon S. H. (2017) HDAC6 regulates sensitivity to cell death in response to stress and post-stress recovery. Cell Stress Chaperones 22, 253&#x2013;261 10.1007/s12192-017-0763-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0763-3</ArticleId><ArticleId IdType="pmc">PMC5352599</ArticleId><ArticleId IdType="pubmed">28116619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan H. X., Wang Z., Yu F. X., Li F., Russell R. C., Jewell J. L., and Guan K. L. (2015) NLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibition. Genes Dev. 29, 2362&#x2013;2376 10.1101/gad.265116.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.265116.115</ArticleId><ArticleId IdType="pmc">PMC4691891</ArticleId><ArticleId IdType="pubmed">26588989</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M., Lee S., Kim K., Lee S., Kim S. R., and Kim H. J. (2019) Inhibition of MEK5 suppresses TDP-43 toxicity via the mTOR-independent activation of the autophagy-lysosome pathway. Biochem. Biophys. Res. Commun. 513, 925&#x2013;932 10.1016/j.bbrc.2019.04.088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.04.088</ArticleId><ArticleId IdType="pubmed">31005259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S. H., Park Y., Yoon S. K., and Yoon J. B. (2010) Osmotic stress inhibits proteasome by p38 MAPK-dependent phosphorylation. J. Biol. Chem. 285, 41280&#x2013;41289 10.1074/jbc.M110.182188</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.182188</ArticleId><ArticleId IdType="pmc">PMC3009853</ArticleId><ArticleId IdType="pubmed">21044959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hock E. M., Maniecka Z., Hruska-Plochan M., Reber S., Laferri&#xe8;re F., Sahadevan M. K. S., Ederle H., Gittings L., Pelkmans L., Dupuis L., Lashley T., Ruepp M. D., Dormann D., and Polymenidou M. (2018) Hypertonic stress causes cytoplasmic translocation of neuronal, but not astrocytic, FUS due to impaired transportin function. Cell Rep. 24, 987&#x2013;1000.e7 10.1016/j.celrep.2018.06.094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.094</ArticleId><ArticleId IdType="pubmed">30044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiken C. T., Kaake R. M., Wang X., and Huang L. (2011) Oxidative stress-mediated regulation of proteasome complexes. Mol. Cell. Proteomics 10, R110.006924 10.1074/mcp.M110.006924</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M110.006924</ArticleId><ArticleId IdType="pmc">PMC3098605</ArticleId><ArticleId IdType="pubmed">21543789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajares M., Jim&#xe9;nez-Moreno N., Dias I. H. K., Debelec B., Vucetic M., Fladmark K. E., Basaga H., Ribaric S., Milisav I., and Cuadrado A. (2015) Redox control of protein degradation. Redox Biol. 6, 409&#x2013;420 10.1016/j.redox.2015.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.07.003</ArticleId><ArticleId IdType="pmc">PMC4576413</ArticleId><ArticleId IdType="pubmed">26381917</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb A. E., and Brunet A. (2014) FOXO transcription factors: key regulators of cellular quality control. Trends Biochem. Sci. 39, 159&#x2013;169 10.1016/j.tibs.2014.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2014.02.003</ArticleId><ArticleId IdType="pmc">PMC4021867</ArticleId><ArticleId IdType="pubmed">24630600</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J., McLeod L. E., Vries R. G., Flynn A., Wang X., and Proud C. G. (2002) Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur. J. Biochem. 269, 3076&#x2013;3085 10.1046/j.1432-1033.2002.02992.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2002.02992.x</ArticleId><ArticleId IdType="pubmed">12071973</ArticleId></ArticleIdList></Reference><Reference><Citation>Plescher M., Teleman A. A., and Demetriades C. (2015) TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1. Sci. Rep. 5, 13828 10.1038/srep13828</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13828</ArticleId><ArticleId IdType="pmc">PMC4642562</ArticleId><ArticleId IdType="pubmed">26345496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Oyarzun D., Troncoso R., Kretschmar C., Hernando C., Budini M., Morselli E., Lavandero S., and Criollo A. (2017) Hyperosmotic stress stimulates autophagy via polycystin-2. Oncotarget 8, 55984&#x2013;55997 10.18632/oncotarget.18995</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.18995</ArticleId><ArticleId IdType="pmc">PMC5593539</ArticleId><ArticleId IdType="pubmed">28915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardis A., Zampieri S., Canterini S., Newell K. L., Stuani C., Murrell J. R., Ghetti B., Fiorenza M. T., Bembi B., and Buratti E. (2016) Altered localization and functionality of TAR DNA binding protein 43 (TDP-43) in Niemann-Pick disease type C. Acta Neuropathol. Commun. 4, 52 10.1186/s40478-016-0325-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0325-4</ArticleId><ArticleId IdType="pmc">PMC4870731</ArticleId><ArticleId IdType="pubmed">27193329</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H. A., and Mackenzie I. R. (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922&#x2013;2931 10.1093/brain/awp214</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp214</ArticleId><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H., Klijnsma K. Y., de Koning I., van der Lugt A., Chiu W. Z., Azmani A., Rozemuller A. J., and van Swieten J. C. (2010) Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 257, 747&#x2013;753 10.1007/s00415-009-5404-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5404-z</ArticleId><ArticleId IdType="pmc">PMC2864899</ArticleId><ArticleId IdType="pubmed">19946779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I. R., and Neumann M. (2016) Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J. Neurochem. 138, Suppl. 1, 54&#x2013;70 10.1111/jnc.13588</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13588</ArticleId><ArticleId IdType="pubmed">27306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S., Holmstr&#xf6;m K. M., Skujat D., Fiesel F. C., Rothfuss O. C., Kahle P. J., and Springer W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12, 119&#x2013;131 10.1038/ncb2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2012</ArticleId><ArticleId IdType="pubmed">20098416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>